This inventor holds 2 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Carna Biosciences, Inc.. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: Wataru Kawahata: Innovator in Pharmaceutical Chemistry
Introduction
Wataru Kawahata is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Kawahata's work focuses on developing novel compounds for medical applications.
Latest Patents
Kawahata's latest patents include the development of oxoisoquinoline derivatives. This invention involves an oxoisoquinoline compound that can be used in pharmaceutical compositions for treating B-cell lymphoma. The method entails administering the oxoisoquinoline compound or its pharmaceutically acceptable salt to patients. Additionally, he has created a triazine derivative, which aims to provide a novel compound with specific chemical properties.
Career Highlights
Wataru Kawahata is currently associated with Carna Biosciences, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options in the pharmaceutical industry.
Collaborations
Kawahata has collaborated with esteemed colleagues such as Takao Kiyoi and Takayuki Irie. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Wataru Kawahata's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to advancing medical science. His innovative work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile